Today: 8 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson shares rose 1.2% to $227.06 after the FDA approved Darzalex Faspro for use with the VRd regimen in newly diagnosed multiple myeloma patients ineligible for stem cell transplant. The approval is based on the CEPHEUS trial, which showed improved outcomes. The move comes as Medicare named 15 drugs for future price negotiations, pressuring the sector.
28 January 2026
··
Constellation Energy stock edges lower as PJM power prices spike in deep freeze — what to watch next for CEG

Constellation Energy stock edges lower as PJM power prices spike in deep freeze — what to watch next for CEG

Constellation Energy shares slipped 0.2% to $288.12 Wednesday as PJM Interconnection reported spot power prices above $1,000/MWh in parts of the Mid-Atlantic amid cold-driven grid strain. About 1.6 million shares traded. PJM cited nearly 21 GW of generation outages and warned of possible controlled outages. Constellation recently completed its Calpine acquisition and awaits an earnings report projected for Feb. 17.
28 January 2026
··
Abbott Laboratories stock price slides as Argus cuts target and CEO Ford discloses share buy

Abbott Laboratories stock price slides as Argus cuts target and CEO Ford discloses share buy

Abbott Laboratories shares fell about 2% to $106.12 Wednesday after Argus cut its price target to $140, following last week’s earnings warning. CEO Robert Ford bought 18,800 shares on Jan. 23 at an average $107.13, according to an SEC filing. The broader healthcare sector slipped ahead of the Federal Reserve’s rate decision. Abbott cited weak nutrition and diagnostics sales and higher costs for its recent profit miss.
28 January 2026
·
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health shares jumped 6% to $343.14 Wednesday after the company set a 2026 profit floor despite warning of lower revenue. The move followed a $80 billion sector selloff triggered by new Medicare payment proposals. Elevance projected 2026 adjusted earnings of at least $25.50 per share and year-end enrollment up to 43.875 million. Fourth-quarter operating revenue reached $49.3 billion.
28 January 2026
··
Nvidia stock price rises on China H200 nod as AI chip shares keep Wall Street near 7,000

Nvidia stock price rises on China H200 nod as AI chip shares keep Wall Street near 7,000

Nvidia shares rose 1.7% after China approved ByteDance, Alibaba, and Tencent to buy over 400,000 H200 AI chips, though no orders have been placed due to strict conditions. Intel and Micron led a rally in chip stocks as investors awaited Fed and Big Tech earnings. Micron announced a $24 billion memory chip plant in Singapore. SK Hynix and ASML both reported record results on AI demand.
28 January 2026
·········
Gold price breaks $5,300 record before Fed decision, lifting GLD and miners

Gold price breaks $5,300 record before Fed decision, lifting GLD and miners

Gold prices hit a record $5,311 an ounce Wednesday as the U.S. dollar rebounded from a two-year low ahead of the Federal Reserve’s policy announcement. Spot gold rose 1.9% to $5,289.48 by midday, while February futures gained 4%. Retail demand spiked in Asia, with crowds reported at gold shops in Shanghai and Hong Kong. Traders awaited Fed Chair Jerome Powell’s remarks for signals on interest rates.
28 January 2026
···
Texas Instruments stock jumps nearly 10% as AI data-center demand lifts chipmakers

Texas Instruments stock jumps nearly 10% as AI data-center demand lifts chipmakers

Texas Instruments shares rose nearly 10% after forecasting stronger-than-expected first-quarter revenue, citing surging demand for analog chips in AI data centers. Seagate jumped almost 20% on a bullish storage outlook, while Intel gained close to 11%. Investors awaited the Federal Reserve’s policy decision and major tech earnings due Wednesday. ASML reported record Q4 orders and plans 1,700 job cuts.
28 January 2026
······
Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

The Dow rose 49.62 points to 49,053.03 by midday Wednesday as the S&P 500 briefly topped 7,000 before retreating. Intel jumped 11.3%, while UnitedHealth plunged nearly 20% after the Trump administration proposed a 0.09% Medicare Advantage rate hike for 2027. The Fed is expected to hold rates steady. Seagate surged 19.3% on earnings.
28 January 2026
·······
Bloom Energy stock jumps as China Renaissance starts coverage; targets hit $207

Bloom Energy stock jumps as China Renaissance starts coverage; targets hit $207

Bloom Energy shares jumped 7.8% to $164.18 by early afternoon Wednesday after several analysts raised price targets, citing strong demand for data center and on-site power solutions. China Renaissance initiated coverage with a Buy and a $207 target, while Barclays set $153 and flagged valuation risks. Jefferies and Baird also lifted targets. Bloom reports Q4 results Feb. 5, with investors eyeing 2026 guidance and manufacturing updates.
28 January 2026
··
Applied Digital stock price slides as APLD gives back Nvidia-CoreWeave rally — what investors watch next

Applied Digital stock price slides as APLD gives back Nvidia-CoreWeave rally — what investors watch next

Applied Digital Corp shares fell 5.2% to $39.19 Wednesday after a recent surge tied to AI data-center demand and CoreWeave’s expansion. The drop followed Nvidia’s $2 billion investment in CoreWeave and news of a partnership to build over 5 gigawatts of AI data centers by 2030. Applied Digital recently broke ground on a new 430-megawatt campus. The company warned in filings that project delays could impact revenue.
28 January 2026
··
Western Digital stock jumps 11% as Seagate’s AI-driven outlook ripples through storage names

Western Digital stock jumps 11% as Seagate’s AI-driven outlook ripples through storage names

Western Digital shares surged 11.3% to $281.31 Wednesday, following Seagate’s strong quarterly forecast tied to AI-driven storage demand. Seagate projected third-quarter revenue of about $2.90 billion and adjusted EPS of $3.40. Western Digital will report earnings after markets close Thursday. Analysts recently raised price targets for both companies, citing rising demand for data center storage.
28 January 2026
···
Roper stock slips again after outlook miss; Deltek in focus as U.S. funding deadline nears

Roper stock slips again after outlook miss; Deltek in focus as U.S. funding deadline nears

Roper Technologies shares fell about 2% Wednesday after its 2026 revenue and profit forecast missed analyst estimates. The company cited weaker demand at its Deltek division, which serves government contractors, and warned that possible U.S. government shutdowns could further impact business. Fourth-quarter revenue reached $2.06 billion, with adjusted EPS at $5.21. Stifel downgraded the stock and cut its price target sharply.
28 January 2026
··
Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Pfizer shares fell 1.8% to $26.02 after U.S. Medicare included Xeljanz in its upcoming drug price negotiations, set to begin in 2026 with prices effective in 2028. The Centers for Medicare & Medicaid Services named 15 drugs for talks, and companies must decide by February 28 whether to participate. Investors are awaiting Pfizer’s February 3 earnings for updates on pricing risks.
28 January 2026
······
Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Mastercard shares slipped 0.1% to $519.71 by midday Wednesday, trailing Visa’s gains ahead of Thursday’s earnings report. The company unveiled a new AI-driven “Agent Suite” Tuesday, aiming for a Q2 2026 launch. Cantor Fitzgerald initiated coverage with an Overweight rating and a $650 price target. Mastercard stock remains about 13.5% below its 52-week high.
28 January 2026
···
1 … 172 173 174 175 176 … 690
Go toTop